Mark Schiller
Psychiatry · Corte Madera, CANPI 1245445170
Payments from drug & device makers
Across 258 payments — averaging $22.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Alkermes, Inc.$881
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$659
- Lundbeck LLC$647
- Indivior Inc.$574
- Takeda Pharmaceuticals U.S.A., Inc.$232
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,62699%
- Education$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 59 | $1,014 |
| Alkermes, Inc. | 34 | $881 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $659 |
| Lundbeck LLC | 29 | $647 |
| Indivior Inc. | 23 | $574 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $232 |
| Otsuka America Pharmaceutical, Inc. | 10 | $223 |
| Teva Pharmaceuticals USA, Inc. | 7 | $213 |
| Johnson & Johnson | 9 | $207 |
| Axsome Therapeutics, Inc. | 7 | $204 |
| E.r. Squibb & Sons, L.L.C. | 3 | $187 |
| Sunovion Pharmaceuticals Inc. | 17 | $148 |
| Vanda Pharmaceuticals Inc. | 5 | $129 |
| Braeburn Inc. | 2 | $76 |
| Neurocrine Biosciences, Inc. | 2 | $59 |
| Orexo US, Inc. | 3 | $52 |
| Merck | 2 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Ironshore Pharmaceuticals Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Alfasigma USA, Inc. | 1 | $18 |
| MDD US Operations, LLC | 1 | $16 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,676 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylphenidate ErMethylphenidate Hcl | 18 | $1,859 |
| Gabapentin | 48 | $1,002 |
| Bupropion XlBupropion Hcl | 39 | $740 |
| Quetiapine Fumarate | 12 | $402 |
| Lurasidone Hcl | 16 | $386 |
| Buspirone Hcl | 14 | $342 |
| Mirtazapine | 37 | $328 |
| Trazodone Hcl | 46 | $318 |
| Alprazolam | 26 | $255 |
| Lithium Carbonate ErLithium Carbonate | 13 | $192 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $139 |
| Escitalopram Oxalate | 11 | $95 |
| Clonazepam | 27 | $72 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Corte Madera
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.